111 results
Page 2 of 6
S-4
dbq5b8c2
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
tzfzzad 0urn0g
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
gzjxgwph6qkzz48
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
DEFC14A
b8ijcn mqj2j8azpxau5
5 Dec 22
Proxy in contested solicitation
5:12pm
PRER14A
sbi8fqcib4b9rjnyu
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
fl2lv3vwhx u5rkmm
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-1.1
6c1 3z0wgvxl24nz7
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
xe5bn4re
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-10.1
u8uvzjc8e0 fv
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
424B5
vr12vh84jylivczucjs
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
xs5ny0r
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
424B5
0aowcuh
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
9qqx0c7o
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
2ulfy72
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm